In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Luis Paz-Ares discusses treatment options in the…
Browsing: Acute Lymphoblastic Leukemia
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Sanjay Popat discusses mutation-independent approaches to the…
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Fernando López-RÃos arguest that liquid biopsy will…
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Thomas Newsom-Davis argues that liquid biopsy will…
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Luis Paz-Ares discusses HER-2, BRAF, KRAS, and…
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Céline Mascaux discusses treatment strategies in both…
With the recent news that Sen. John McCain was diagnosed with glioblastoma, Ashley Sumrall, MD, division chief of neuro-oncology at…
Surgeon Anne Peled, MD and patient Sue Yeres — herself a breast cancer activist — tell the story of Sue’s…
Dr. David Edmonson describes how the BioZorb implant helps improve cosmetic results for breast cancer patients — while also aiding…
Trisha Marsolini, RN, OCN, BMTCN and Angela Rodriguez, MSN, RN, CNS-BC, AFN-BC, OCN, Associate Director of Clinical Operations Infusion/CTU/Phase 1…
Kathleen Shannon Dorcy, PhD, RN, Director of Clinical Nursing Research of Seattle Cancer Care Alliance discusses Ethical Considerations of Precision…
Naomi Heinecke, LPN and Terri Cunningham, MSN, RN, AOCN of Seattle Cancer Care Alliance discuss Creating an Accurate Home Medication…
Arlyce Coumar, BSN, RN, OCN, BMTCN of Seattle Cancer Care Alliance discusses A Model for Global Engagement of Oncology Nurses…
Michelle Mitchell, BSN, RN, OCN, Sharon Rockwell, BSN, RN, OCN, CRNI, Alex Dorcy, BSN, RN, OCN, and Annette English, BSN,…
Nicole Falkin, BSN, RN, OCN and Anne Nagengast, BSN, RN, BMTCN of Seattle Cancer Care Alliance discuss Managing Cytokine Release…
Karen Anderson, MN, RN, AOCNS, BMTCN, CRNI and Anne Reese, BSN, RN, OCN of Seattle Cancer Care Alliance discuss Nursing…
Expanding beyond the checkpoints: New vaccines and other immunologic strategies for NSCLC Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Lung…
Unique toxicities of immunotherapy Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Lung © 2017 Imedex, LLC.
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vassiliki Papadimitrakopoulou argues in favor of the use…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Naiyer Rizvi argues in favor of single drug…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Andrew R. Haas discusses the biological basis of…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Joshua Bauml discusses whether there has been progress…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Evan W. Alley discusses the targeting of HER2,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Ranee Mehra discusses the therapeutic implications of EML4/ALK,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Pallavi Kumar discusses strategies for how to conduct…
In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute, provides a brief overview of the…
In this Ask the Expert segment, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center responds to…
In this Ask the Expert segment, a Patient Power community member wants to know if and why a bone marrow…
Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being incorporated into lung cancer treatment…
Jack West, MD of Swedish Cancer Institute discusses the use of IDO inhibitors for the treatment of lung cancer patients…
Jack West, MD of Swedish Cancer Institute discusses the use of durvalumab for patients with stage III non-small cell lung…
Jack West, MD of Swedish Cancer Institute explains the relevance to test for PD-L1 in lung cancer at the 2017…
Jack West, MD of Swedish Cancer Institute discusses the combination of immunotherapies for future clinical research at the 2017 Annual…
Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being combined with chemotherapy and targeted…
Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada discusses the results of the LATITUDE study and its impact…
Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada explains how he chooses the right prostate cancer patient for…
Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada explains whether AR-V7 testing is ready for prime time at…
Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada discusses the data from the CHAARTED, STAMPEDE, and LATITUDE studies…
Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada discusses cost implications when abiraterone becomes standard care for prostate…
Debu Tripathy, MD of MD Anderson Cancer Center explains how immunotherapies are being studied and possibly integrated into the treatment…
Debu Tripathy, MD of MD Anderson Cancer Center gives an overview of the MONALEESA-2 study at the 2017 Annual Meeting…
Debu Tripathy, MD of MD Anderson Cancer Center gives an overview of the MONARCH-2 trial and explains its impact on…
Debu Tripathy, MD of MD Anderson Cancer Center discusses the impact of the APHINITY trial on treating patients with breast…
Anurag Singh, MD, shares new research indicating that non-small cell lung cancer (NSCLC) patients may benefit from a single dose…
Stereotactic body radiation therapy (SBRT) combined with surgery can be used to treat metastatic kidney cancer, according to Roswell Park…
George R. Simon, MD, FACP, FCCP of MD Anderson Cancer Center gives an overview of the Checkmate 032 and CTONG…
George R. Simon, MD, FACP, FCCP of MD Anderson Cancer Center gives an overview of the most promising data on…
David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the use of pomalidomide for multiple myeloma patients progressing…
David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the use of CAR T-cell therapy in treating multiple…
David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the combination of pembrolizumab and lenalidomide for treating patients…